4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one

C159H308F2N30O14 — CID 160817504

IUPAC4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one
SMILESCC(C)CN1CC(C(=O)N(C)C)C1.CC(C)CN1CC(C(=O)N2CC(O)C2)C1.CC(C)CN1CC(N2CC(O)C2)C1.CC(C)CN1CC(N2CCC(F)(F)CC2)C1.CC(C)CN1CC(N2CCC(O)C2)C1.CC(C)CN1CC(N2CCC(O)CC2)C1.CC(C)CN1CC(N2CCCC(O)C2)C1.CC(C)CN1CC(N2CCCC2)C1.CC(C)CN1CC(N2CCCCC2)C1.CC(C)CN1CC(N2CCNC(=O)C2)C1.CC(C)CN1CC(O)(CN(C)C(C)(C)C(N)=O)C1.CC(C)CN1CC2(CCN(C)C(=O)C2)C1.CC(C)CN1CC2(CCN(C)C(=O)C2)C1.CC(C)CN1CC2(CNC(=O)CO2)C1
InChIInChI=1S/C13H27N3O2.C12H22F2N2.2C12H22N2O.2C12H24N2O.C12H24N2.C11H21N3O.C11H20N2O2.C11H22N2O.C11H22N2.C10H18N2O2.2C10H20N2O/c1-10(2)6-16-8-13(18,9-16)7-15(5)12(3,4)11(14)17;1-10(2)7-15-8-11(9-15)16-5-3-12(13,14)4-6-16;2*1-10(2)7-14-8-12(9-14)4-5-13(3)11(15)6-12;1-10(2)7-13-8-11(9-13)14-5-3-12(15)4-6-14;1-10(2)6-13-7-11(8-13)14-5-3-4-12(15)9-14;1-11(2)8-13-9-12(10-13)14-6-4-3-5-7-14;1-9(2)5-13-6-10(7-13)14-4-3-12-11(15)8-14;1-8(2)3-12-4-9(5-12)11(15)13-6-10(14)7-13;1-9(2)5-12-6-10(7-12)13-4-3-11(14)8-13;1-10(2)7-12-8-11(9-12)13-5-3-4-6-13;1-8(2)3-12-6-10(7-12)5-11-9(13)4-14-10;1-8(2)3-11-4-9(5-11)12-6-10(13)7-12;1-8(2)5-12-6-9(7-12)10(13)11(3)4/h10,18H,6-9H2,1-5H3,(H2,14,17);10-11H,3-9H2,1-2H3;2*10H,4-9H2,1-3H3;2*10-12,15H,3-9H2,1-2H3;11-12H,3-10H2,1-2H3;9-10H,3-8H2,1-2H3,(H,12,15);8-10,14H,3-7H2,1-2H3;9-11,14H,3-8H2,1-2H3;10-11H,3-9H2,1-2H3;8H,3-7H2,1-2H3,(H,11,13);8-10,13H,3-7H2,1-2H3;8-9H,5-7H2,1-4H3
InChIKeySFCCKXQJKINJSM-UHFFFAOYSA-N
MW2902.40 g/mol
LogP9.57
Rot. Bonds42

About 4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one

4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one (PubChem CID 160817504) has the molecular formula C159H308F2N30O14 and a molecular weight of 2902.40 g/mol. Its IUPAC name is 4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one.

Molecular Properties

Compound Name4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one
PubChem CID160817504
Molecular FormulaC159H308F2N30O14
Molecular Weight2902.40 g/mol
Exact Mass2900.43
IUPAC Name4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one
SMILESCC(C)CN1CC(C(=O)N(C)C)C1.CC(C)CN1CC(C(=O)N2CC(O)C2)C1.CC(C)CN1CC(N2CC(O)C2)C1.CC(C)CN1CC(N2CCC(F)(F)CC2)C1.CC(C)CN1CC(N2CCC(O)C2)C1.CC(C)CN1CC(N2CCC(O)CC2)C1.CC(C)CN1CC(N2CCCC(O)C2)C1.CC(C)CN1CC(N2CCCC2)C1.CC(C)CN1CC(N2CCCCC2)C1.CC(C)CN1CC(N2CCNC(=O)C2)C1.CC(C)CN1CC(O)(CN(C)C(C)(C)C(N)=O)C1.CC(C)CN1CC2(CCN(C)C(=O)C2)C1.CC(C)CN1CC2(CCN(C)C(=O)C2)C1.CC(C)CN1CC2(CNC(=O)CO2)C1
InChIInChI=1S/C13H27N3O2.C12H22F2N2.2C12H22N2O.2C12H24N2O.C12H24N2.C11H21N3O.C11H20N2O2.C11H22N2O.C11H22N2.C10H18N2O2.2C10H20N2O/c1-10(2)6-16-8-13(18,9-16)7-15(5)12(3,4)11(14)17;1-10(2)7-15-8-11(9-15)16-5-3-12(13,14)4-6-16;2*1-10(2)7-14-8-12(9-14)4-5-13(3)11(15)6-12;1-10(2)7-13-8-11(9-13)14-5-3-12(15)4-6-14;1-10(2)6-13-7-11(8-13)14-5-3-4-12(15)9-14;1-11(2)8-13-9-12(10-13)14-6-4-3-5-7-14;1-9(2)5-13-6-10(7-13)14-4-3-12-11(15)8-14;1-8(2)3-12-4-9(5-12)11(15)13-6-10(14)7-13;1-9(2)5-12-6-10(7-12)13-4-3-11(14)8-13;1-10(2)7-12-8-11(9-12)13-5-3-4-6-13;1-8(2)3-12-6-10(7-12)5-11-9(13)4-14-10;1-8(2)3-11-4-9(5-11)12-6-10(13)7-12;1-8(2)5-12-6-9(7-12)10(13)11(3)4/h10,18H,6-9H2,1-5H3,(H2,14,17);10-11H,3-9H2,1-2H3;2*10H,4-9H2,1-3H3;2*10-12,15H,3-9H2,1-2H3;11-12H,3-10H2,1-2H3;9-10H,3-8H2,1-2H3,(H,12,15);8-10,14H,3-7H2,1-2H3;9-11,14H,3-8H2,1-2H3;10-11H,3-9H2,1-2H3;8H,3-7H2,1-2H3,(H,11,13);8-10,13H,3-7H2,1-2H3;8-9H,5-7H2,1-4H3
InChIKeySFCCKXQJKINJSM-UHFFFAOYSA-N
XLogP9.57
TPSA387.66 Ų
H-Bond Donors9
H-Bond Acceptors37
Rotatable Bonds42
Heavy Atoms205
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002902.40
LogP ≤ 59.57
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1037

Analyze 4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one?
The IUPAC name of 4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one (CID 160817504) is 4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one.
What is the SMILES notation for 4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one?
The canonical SMILES for 4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one is CC(C)CN1CC(C(=O)N(C)C)C1.CC(C)CN1CC(C(=O)N2CC(O)C2)C1.CC(C)CN1CC(N2CC(O)C2)C1.CC(C)CN1CC(N2CCC(F)(F)CC2)C1.CC(C)CN1CC(N2CCC(O)C2)C1.CC(C)CN1CC(N2CCC(O)CC2)C1.CC(C)CN1CC(N2CCCC(O)C2)C1.CC(C)CN1CC(N2CCCC2)C1.CC(C)CN1CC(N2CCCCC2)C1.CC(C)CN1CC(N2CCNC(=O)C2)C1.CC(C)CN1CC(O)(CN(C)C(C)(C)C(N)=O)C1.CC(C)CN1CC2(CCN(C)C(=O)C2)C1.CC(C)CN1CC2(CCN(C)C(=O)C2)C1.CC(C)CN1CC2(CNC(=O)CO2)C1.
What is the InChIKey of 4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one?
The InChIKey is SFCCKXQJKINJSM-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H27N3O2.C12H22F2N2.2C12H22N2O.2C12H24N2O.C12H24N2.C11H21N3O.C11H20N2O2.C11H22N2O.C11H22N2.C10H18N2O2.2C10H20N2O/c1-10(2)6-16-8-13(18,9-16)7-15(5)12(3,4)11(14)17;1-10(2)7-15-8-11(9-15)16-5-3-12(13,14)4-6-16;2*1-10(2)7-14-8-12(9-14)4-5-13(3)11(15)6-12;1-10(2)7-13-8-11(9-13)14-5-3-12(15)4-6-14;1-10(2)6-13-7-11(8-13)14-5-3-4-12(15)9-14;1-11(2)8-13-9-12(10-13)14-6-4-3-5-7-14;1-9(2)5-13-6-10(7-13)14-4-3-12-11(15)8-14;1-8(2)3-12-4-9(5-12)11(15)13-6-10(14)7-13;1-9(2)5-12-6-10(7-12)13-4-3-11(14)8-13;1-10(2)7-12-8-11(9-12)13-5-3-4-6-13;1-8(2)3-12-6-10(7-12)5-11-9(13)4-14-10;1-8(2)3-11-4-9(5-11)12-6-10(13)7-12;1-8(2)5-12-6-9(7-12)10(13)11(3)4/h10,18H,6-9H2,1-5H3,(H2,14,17);10-11H,3-9H2,1-2H3;2*10H,4-9H2,1-3H3;2*10-12,15H,3-9H2,1-2H3;11-12H,3-10H2,1-2H3;9-10H,3-8H2,1-2H3,(H,12,15);8-10,14H,3-7H2,1-2H3;9-11,14H,3-8H2,1-2H3;10-11H,3-9H2,1-2H3;8H,3-7H2,1-2H3,(H,11,13);8-10,13H,3-7H2,1-2H3;8-9H,5-7H2,1-4H3.
What are the key properties of 4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one?
4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one has a molecular weight of 2902.40 g/mol, XLogP of 9.57, 42 rotatable bonds, 9 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 4,4-difluoro-1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;N,N-dimethyl-1-(2-methylpropyl)azetidine-3-carboxamide;(3-hydroxyazetidin-1-yl)-[1-(2-methylpropyl)azetidin-3-yl]methanone;2-[[3-hydroxy-1-(2-methylpropyl)azetidin-3-yl]methyl-methylamino]-2-methylpropanamide;bis(7-methyl-2-(2-methylpropyl)-2,7-diazaspiro[3.5]nonan-6-one);1-[1-(2-methylpropyl)azetidin-3-yl]azetidin-3-ol;4-[1-(2-methylpropyl)azetidin-3-yl]piperazin-2-one;1-[1-(2-methylpropyl)azetidin-3-yl]piperidine;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-3-ol;1-[1-(2-methylpropyl)azetidin-3-yl]piperidin-4-ol;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidine;1-[1-(2-methylpropyl)azetidin-3-yl]pyrrolidin-3-ol;2-(2-methylpropyl)-5-oxa-2,8-diazaspiro[3.5]nonan-7-one is sourced from PubChem (CID 160817504), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).